Tumour-suppressor activity of H19 RNA
Y Hao, T Crenshaw, T Moulton, E Newcomb, B Tycko - Nature, 1993 - nature.com
Y Hao, T Crenshaw, T Moulton, E Newcomb, B Tycko
Nature, 1993•nature.comLOSS of heterozygosity in certain human embryonal tumours implicates a tumour-
suppressor gene at chromosome 11p15. 5 and selective loss of maternal alleles suggests
that this gene is paternally imprinted1–4. The human HI9 gene maps to 11p1S. 5, is
expressed in differentiating fetal cells5–11 and is paternally imprinted12–16. We report here
that two embryonal tumour cell lines, RD and G401, showed growth retardation and
morphological changes when transfected with an H19 expression construct. More …
suppressor gene at chromosome 11p15. 5 and selective loss of maternal alleles suggests
that this gene is paternally imprinted1–4. The human HI9 gene maps to 11p1S. 5, is
expressed in differentiating fetal cells5–11 and is paternally imprinted12–16. We report here
that two embryonal tumour cell lines, RD and G401, showed growth retardation and
morphological changes when transfected with an H19 expression construct. More …
Abstract
LOSS of heterozygosity in certain human embryonal tumours implicates a tumour-suppressor gene at chromosome 11p15.5 and selective loss of maternal alleles suggests that this gene is paternally imprinted1–4. The human HI9 gene maps to 11p1S.5, is expressed in differentiating fetal cells5–11 and is paternally imprinted12–16. We report here that two embryonal tumour cell lines, RD and G401, showed growth retardation and morphological changes when transfected with an H19 expression construct. More importantly, clonogenicity in soft agar and tumorigenicity in nude mice were abrogated in the G401-H19 transfectants. In addition to demonstrating its tumour-suppressor potential, this transfection system should help structural and functional studies of the enigmatic H19 gene.
nature.com
